REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/09/2026
Back to search
Official data from USPTO
IG ISOLO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IG ISOLO
ST13
US500000086240194Class
41, 44
Filing
86240194
Registration
5200229
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
05/10/2026
Trademark type
Word
Nice classes
41, 44
Filing date
04/02/2014
Registration date
05/09/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
05/10/2026
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/31/2016
First use in commerce
07/31/2016
Drawing code
4
Owner type
99
Owner location
Bern 22, CH
Examiner
DOMBROW, COLLEEN M
Law office
L10
Holders and representatives
Holders
CSL Behring AG
CSL Behring AG
Representatives
Scott D. Woldow Smith, Gambrell & Russell, LLP
Technical classification
Nice Classes
Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Education and healthcare educational servicesproviding training and programs concerning awareness and consequence of hemolysisthe risk of hemolysis occurring in certain patients receiving immunoglobulin infusion therapy and the identification and treatment with intravenous immunoglobulin therapy of patients in whom hemolysis may develop
Class 44
Providing medical and pharmaceutical information to patients and healthcare practitionersproviding medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis
Publications
History of USPTO decisions and trademark events.
58 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/03/2023
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
10/03/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/19/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
09/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2023
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
09/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2023
ES8R
TEAS SECTION 8 RECEIVED
04/11/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/09/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/05/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/04/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/14/2017
IUAF
USE AMENDMENT FILED
03/06/2017
EISU
TEAS STATEMENT OF USE RECEIVED
03/06/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/11/2017
EX4G
SOU EXTENSION 4 GRANTED
01/10/2017
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
12/16/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/16/2016
INCE
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
12/13/2016
EXT4
SOU EXTENSION 4 FILED
11/29/2016
EEXT
SOU TEAS EXTENSION RECEIVED
11/29/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/28/2016
EX3G
SOU EXTENSION 3 GRANTED
04/27/2016
EXT3
SOU EXTENSION 3 FILED
04/12/2016
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/03/2015
EX2G
SOU EXTENSION 2 GRANTED
12/02/2015
EXT2
SOU EXTENSION 2 FILED
11/20/2015
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/19/2015
EX1G
SOU EXTENSION 1 GRANTED
06/18/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/18/2015
EXT1
SOU EXTENSION 1 FILED
05/20/2015
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/02/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/07/2014
PUBO
PUBLISHED FOR OPPOSITION
10/07/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/17/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/02/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/29/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2014
ALIE
ASSIGNED TO LIE
08/26/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/22/2014
GNRT
NON-FINAL ACTION E-MAILED
05/22/2014
CNRT
NON-FINAL ACTION WRITTEN
05/22/2014
DOCK
ASSIGNED TO EXAMINER
05/16/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/15/2014
NWAP
NEW APPLICATION ENTERED
04/05/2014
Continuous trademark protection
Get notified about every new filing that threatens IG ISOLO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.